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Adult BM is composed of hematopoietic stem 
cells (HSCs) and tissue stem cells, which are 
often referred to as fibroblast CFUs (CFU-Fs), 
marrow stromal cells/mesenchymal stem cells 
(MSCs), or mesenchymal progenitor cells (MPCs; 
Friedenstein et al., 1974; Prockop, 1997; Conget 
and Minguell, 1999; Pittenger et al., 1999). As 
information is gathered about MSCs, parallels 
are often drawn between them and the exten-
sively characterized HSCs. HSCs were initially 
identified by Till and McCulloch (1961), who 
called them spleen CFUs (CFU-Ss), and MSCs 
were first described by Friedenstein et al. (1974), 
who called them CFU-Fs. There has since been 
a major divergence in the way the two stem cell 
types are studied.
HSCs can be identified prospectively by sur-
face markers, isolated by flow cytometry, and 
transplanted in vivo without being cultured 
in vitro (Smith et al., 1991; Spangrude et al., 1995; 
Osawa et al., 1996; Matsuzaki et al., 2004). In 
contrast, MSCs, which can give rise to multiple 
mesenchymal cell lineages, including adipo-
cytes, chondrocytes, and osteocytes (Prockop, 
1997; Pittenger et al., 1999), are currently iso-
lated by culturing tissues from humans and 
other species (da Silva Meirelles et al., 2006; 
Beltrami et al., 2007). Therefore, most infor-
mation about MSCs comes from in vitro stud-
ies (Pittenger et al., 1999) of heterogeneous 
populations of adherent cells that contain un-
identified, putative stem cells. This is a critical 
difference  because  it  is  the  ability  to  isolate 
HSCs prospectively that has facilitated the rapid 
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Mesenchymal stem cells (MSCs) are defined as cells that undergo sustained in vitro growth 
and can give rise to multiple mesenchymal lineages. Because MSCs have only been isolated 
from tissue in culture, the equivalent cells have not been identified in vivo and little is 
known about their physiological roles or even their exact tissue location. In this study, we 
used phenotypic, morphological, and functional criteria to identify and prospectively isolate 
a subset of MSCs (PDGFR+Sca-1+CD45TER119) from adult mouse bone marrow. Indi-
vidual MSCs generated colonies at a high frequency and could differentiate into hemato-
poietic niche cells, osteoblasts, and adipocytes after in vivo transplantation. Naive MSCs 
resided in the perivascular region in a quiescent state. This study provides the useful 
method needed to identify MSCs as defined in vivo entities.
© 2009 Morikawa et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Figure 1.  Enrichment of mesenchymal stem cells in the PS population. (A–D) Representative flow cytometric profiles of BM mononuclear cells 
stained with CD45, TER119, PDGFR, and Sca-1 without (A and B) or with (C and D) collagenase treatment. (E) Number of CFU-Fs 14 d after plating. Data JEM VOL. 206, October 26, 2009 
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are mean ± SEM (n = 3 per group; **, P < 0.01; †, no colonies observed). (F) Phase-contrast micrographs of CFU-Fs 14 d after plating, derived from 5,000 
PDGFRSca-1+, PDGFR+Sca-1+, PDGFR+Sca1, or 1 × 104 PDGFR-Sca-1 cells. (G) Growth curves of representative populations derived from 5,000 
cells plated. (H) Negative linear relationship between the number of subpopulation BM cells seeded and the proportion of negative colony formation ob-
tained by three independent experiments. (I) Adipogenesis (left) was indicated by neutral lipid vacuoles that stained with oil red O on day 14. Chondro-
genesis (middle) indicated by toluidine blue staining on day 21 and by morphological changes. Osteogenesis (right) indicated by alkaline phosphatase 
staining on day 14. (J) CFU-Cs assays. PS cells (5,000) and CD34 KSL cells (100) were seeded into separate cultures with MethoCult medium. The total 
numbers of colonies counted at 14 d are shown. †, no colonies observed. (K) Phase-contrast micrograph of a representative colony derived from CD34 
KSL cells (top). No colonies arose from PS cells under this condition (bottom). Bars, (F, I, and K) 100 µm. (L) Two-dimensional flow cytometric profile of 
the Hoechst-Red and Hoechst-Blue fluorescence intensity of PI-negative cells (gray) and PS cells (red). Data are representative of three independent 
experiments.
 
progress in understanding their biology. In contrast, because 
our knowledge of MSCs is based solely on the characteriza-
tion of cultured cells, it has been virtually impossible to study 
many of their properties, particularly their function, in vivo.
Recent studies consistently show that MSCs not only 
differentiate  into  mesenchymal  lineage  cells  but  also  into 
neurons (Kohyama et al., 2001; Kondo et al., 2005), skeletal 
muscle (Dezawa et al., 2005), and myocardium (Makino et al., 
1999; Miyahara et al., 2006). Therefore, MSCs are now con-
sidered a potentially effective source for stem cell therapy (Jin 
et al., 2002; Hoffmann et al., 2006). However, safety issues 
still need to be clarified before their clinical use, particularly 
because so many biological aspects of MSCs, such as their 
exact identity and in vivo function, are still unknown.
One disadvantage of the conventional in vitro method for 
isolating MSCs is the unavoidable contamination by hemato-
poietic cells and the cellular heterogeneity of the cultures, 
including various fibroblastic cells. In fact, depending on the 
study, cultured MSCs express a different subset of various cell 
lineage–specific antigens, adhesion molecules, integrins, and 
growth factor receptors (Jiang et al., 2002; da Silva Meirelles 
et al., 2006). Another problem with the current technique is 
that the cultured cells may acquire different characteristics 
from their in vivo state, which could include changes in the 
cell surface markers they express. One example of adherent 
culture-induced change is seen when MSCs, which are read-
ily expanded in culture without loss of multipotency, show 
poor tissue tropism when transplanted, including a failure to 
migrate to the BM (Rombouts and Ploemacher, 2003; Wang 
et al., 2005; Muguruma et al., 2006; Sackstein et al., 2008), 
which limits their therapeutic usefulness. In contrast, some 
studies (including the current one) show that primary BM-
derived MSCs (assayed as CFU-Fs) show a low but efficient 
seeding of the BM upon injection into lethally irradiated 
hosts (Rombouts and Ploemacher, 2003; Koide et al., 2007). 
Because these changes affect fundamental properties of the 
cells, it is difficult to know whether they have retained or lost 
their original characteristics, including their apparent multi-
potency, in vitro.
Most studies on MSCs have been done using human 
cells, not murine cells. Murine MSCs (mMSCs) are far more 
difficult to isolate from the BM and to expand in culture 
than human MSCs (Phinney et al., 1999; Sun et al., 2003; 
Peister et al., 2004). Thus, there is much less information on 
mMSCs than on human MSCs. This reliance on human 
material  means  that  MSCs  cannot  be  studied  in  genetic 
mouse models, which greatly hinders the study of their basic 
biology, engraftment, and therapeutic potential. In fact, with-
out some means for the prospective isolation and purifica-
tion of MSCs, it becomes extremely difficult to ascribe any 
attribute to them with certainty. Hence, there is a clear need 
for specific markers and methods of detection, enumeration, 
and isolation of MSCs from the BM and other tissues where 
they reside.
In a previous study, we identified several mesenchymal 
lineage specific markers in murine BM cells (Koide et al., 
2007), and after initial screening, we determined two possible 
MSC markers (Morikawa et al., 2009), platelet-derived growth 
factor receptor  (PDGFR; an early mesodermal marker; 
Takakura et al., 1997) and stem cell antigen-1 (Sca-1; a known 
stem cell marker; Ortega et al., 1986).
Here, we report a method for identifying and isolating 
MSCs from the adult murine BM, using flow cytometry in 
combination with in vitro function assays. We also report our 
findings on their physiological role, obtained through exist-
ing in vivo precursor cell transplantation assays. We describe 
cell type–specific markers for MSCs, which are useful for 
their prospective isolation as a highly enriched population 
that gives rise to mesenchymal cells at the clonal level with 
high frequency, and demonstrate that these cells are capable 
of in vivo grafting when transplanted systemically.
RESULTS
The PS population is significantly enriched for CFU-Fs 
with differentiation potential
Freshly prepared BM cells were stained with antibodies to 
PDGFR, Sca-1, CD45, and TER119, and analyzed by flow 
cytometry. First, the hematopoietic (CD45+ and TER119+) 
cells were removed from the population by gating on the 
marker signals (Fig. 1, A and C). In the CD45TER119 
gate, four distinct subpopulations (PDGFR+/Sca-1+,  +/, 
/+,  /) were observed (Fig. 1 B). Interestingly, the fre-
quency of cells expressing PDGFR or Sca-1 significantly 
increased when the BM was extracted using collagenase treat-
ment (Fig. 1, B and D; see Materials and methods).
To test whether PDGFR or Sca-1 could be used for 
the prospective isolation of mMSCs, we isolated cells in 
each subpopulation from freshly isolated BM mononuclear 2486 DIRECT ISOLATION METHOD FOR PDGFR+ SCA-1+ mMSCS | Morikawa et al.
A single, self-renewing PS cell can give rise  
to mesenchymal and endothelial lineages
To test the hypothesis that PS cells contained MSCs that 
could differentiate into all three lineages, and to rule out the 
possibility that the PS population contained several different 
kinds of committed progenitors, we performed a differentia-
tion assay with expanded cell colonies derived from a single 
PS cell. For this experiment, sorted PS cells were plated at 
a density of 1-2 × 103 cells on a 100-mm dish. 60 individ-
ual colonies of 50–100 cells were isolated 14 d after plating 
(Fig. 2 A). After several passages, 6 of the 60 independent 
clones were selected for further study and subjected to in vitro 
differentiation assays.
All six clones showed osteogenic and chondrogenic differ-
entiation, assessed by alkaline phosphatase/toluidine blue stain-
ing and the expression of bone and cartilage-related genes, 
including osteopontin, osteocalcin, PTHr, collagen II, collagen X, 
and aggrecan. Four (clones 7, 11, 17, and 19) also underwent 
adipogenic differentiation, demonstrated by oil red O staining 
and  the  expression  of  fat-related  genes,  including  adipsin, 
PPAR, and mLP (Fig. 2, B and C). Interestingly, these four 
clones also underwent angiogenic differentiation, as shown by 
staining for endothelium-associated proteins (PECAM-1 and 
VE-cadherin). These results suggest that MSCs are precursors 
for both mesenchymal and endothelial lineages.
Flow cytometric analysis of clones from single cells re-
vealed  uniform  expression  of  conventional  mesenchymal 
markers CD29, CD49e, CD44, and Sca-1, but only hetero-
geneous expression of CD105 and CD90, which are known 
as marker for cultured human MSCs. Clones with multi-
lineage differentiation potential (#7, 11, 17, and 19) were 
CD105+CD90+, unlike those with limited differentiation 
potential (#26, 42). This observation suggests that CD105 
and CD90 may be useful indicators for multipotency of cul-
tured mMSCs (Fig. S2).
PS cells reside in the perivascular space in vivo
The data presented so far convinced us that the PS popula-
tion represented primary mMSCs. Therefore, we further in-
vestigated the in vivo localization and cell-surface phenotype 
of naive PS cells by whole-mount immunohistochemistry 
(whole-mount IHC) and flow cytometry. As far as we ob-
served in >100 microscopic fields of three individual wild-
type  C57BL/6,  all  PS  cells  were  located  in  the  arterial 
perivascular space near the inner surface of the cortical bone 
(Fig. 3 A), adjacent to vascular smooth muscle cells (vSMCs) 
in BM (Fig. 3 B). PDGFR was expressed in a broader cell 
population  that  included  cells  with  reticular  morphology, 
and relatively weak Sca-1 expression was detected in the en-
dothelial cells (Fig. 3 B).
Because reticular cells located in the perivascular space act 
as hematopoietic niche cells (Sugiyama et al., 2006), we used 
quantitative RT-PCR (Fig. 3 C) and IHC (Fig. 3 D) to exam-
ine the expression of two major paracrine factors that main-
tain hematopoiesis: angiopoietin-1 (Ang-1; Arai et al., 2004) 
and CXCL12 (Sugiyama et al., 2006). We found abundant 
cells (BMMNCs) and performed several in vitro assays to 
determine their characteristics. A traditional CFU-F assay 
showed that the number of colonies per 1,000 cells was 
highest  in  the  PDGFR+Sca-1+CD45TER119  (PS) 
subpopulation; however, the cells in the other subpopula-
tions still produced a significant number of colonies (Fig. 1 E). 
Conventional MSC culture conditions (Phinney et al., 1999; 
Pittenger et al., 1999) yielding fibroblastic/spindle-shaped 
cells indicative of MSCs were only derived in the PS   
cultures on day 14 (Fig. 1 F, top right). The other subpopu-
lations showed different morphologies, such as the cobble-
stone appearance typical of endothelial cells, observed in the 
PDGFRSca-1+ group (Fig. 1 F). In addition, an analysis 
of growth kinetics revealed that only the PS cells prolifer-
ated without senescence, yielding more than 107 cells from 
the original 5,000 cells seeded, with a doubling time of   
50.6 h (Fig. 1 G).
We also observed a negative linear relationship between 
seeding density and colony formation efficiency (Fig. 1 H; 
Stingl et al., 2006). In unfractionated BMMNCs, isolated 
without collagenase treatment, the frequency of CFU-Fs was 
1/2.6 × 106 cells, as described previously (Phinney et al., 
1999). It was 100 times greater when collagenase treatment 
was used (1/3.6 × 104). The frequency of CFU-Fs obtained 
from PS cells was 1 per 22.5 cells, which was consistent 
with the bulk CFU-F assays (Fig. 1 E). Collectively, the PS 
cells showed a 120,000-fold higher CFU-F frequency than 
the unfractionated BMMNCs.
The PS cells’ potential for in vitro mesenchymal lin-
eage differentiation was also investigated (Fig. 1 I). Freshly 
prepared BM cells were separated into the four CD45 
TER119 subpopulations described above, cultured with 
maintenance  media  for  one  or  two  passages,  and  then 
grown  in differentiation-induction media for an additional 
14–21 d. Only the PS cells differentiated robustly into adi-
pocytes,  chondrocytes,  and  osteocytes.  Although  other 
fractions formed a pelletable micro-mass when grown un-
der chondrogenic conditions, the extracellular matrix was 
either scarce or absent, as tested by toluidine blue staining. 
Adipocytes were generated almost solely by the PS popu-
lation, although a very few were occasionally seen in the 
PDGFR+Sca-1 population. PS cells were also detected 
in the BM of other mouse strains, and showed both high 
colony-forming  frequency  and  trilineage  differentiation 
potential at levels comparable to the C57BL/6 PS cells 
(Fig. S1).
As might be expected for MSCs, the PS cells did not 
have any hematopoietic capacity in vitro. They did not con-
tain  any  CFUs  under  hematopoietic  culture  conditions, 
whereas sorted HSCs (CD34KSL cells) formed over 80 col-
onies per 100 cells under the same conditions (Fig. 1, J and K). 
Notably, flow cytometric analysis showed that the PS BM 
fraction did not contain any side population (SP) cells, a pop-
ulation enriched for stem cells, including HSCs, derived from 
a variety of tissues (Fig. 1 L; Goodell et al., 1996; Ono et al., 
2007; Oyama et al., 2007).JEM VOL. 206, October 26, 2009 
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for cultured human MSCs (CD29, CD49e, CD105, CD133, 
and PDGFR). Endothelial cell markers (Flk-1, VEGFR3, 
and CD146, except for CD34) were also uniformly expressed, 
although the fluorescence intensities were lower than that of 
the markers for cultured human MSCs. Markers for HSCs 
(c-kit and CD150) were totally negative. The cells showed 
expression of Ang-1 in the PS cells and of CXCL12 in the 
PDGFR+Sca-1 cells, suggesting that the MSCs constitute 
a hematopoietic niche in the arterial perivascular area near 
the endosteum (Moore and Lemischka, 2006).
Flow cytometric analysis of fresh BMMNCs (Fig. 3 E) 
revealed that PS cells uniformly expressed known markers 
Figure 2.  Identification of MSC potential by clonal assay. (A) Phase-contrast micrographs of a representative colony from a single PS cell. Bar, 
200 µm. (B) Comparison of the differentiation potential of clonally derived cells. Adipogenic (day 14), chondrogenic (day 21), osteogenic (day 14), and 
endothelial (anti-PECAM-1+ and VE-cadherin+, day 21). Bars, 100 µm. (C) RT-PCR analysis of transcription factors and lineage-specific genes. Expression 
of adipocyte- (Adipsin, PPAR, and mLP), chondrocyte- (CollagenII, CollagenX, and Aggrecan), and osteocyte-specific (Osteopontin, Osteocalcin, and PTHr) 
markers, 3 wk after differentiation induction. Data are representative of five independent experiments.2488 DIRECT ISOLATION METHOD FOR PDGFR+ SCA-1+ mMSCS | Morikawa et al.
Figure 3.  In vivo localization and phenotype of PS cells. Whole-mount IHC was performed in bone marrow from wild-type C57BL/6 animals. (A) Rep-
resentative results for quadruple IHC of PDGFR (green), Sca-1 (red), SMA (white), and DAPI (blue) in untreated bone marrow. (B) High magnification image 
of the boxed area in A. PS cells (arrows), vascular smooth muscle cells (arrowheads). Data are representative of three independent recipients. (C) Quantitative 
RT-PCR analysis of Ang-1 and CXCL12. The expression levels detected in PDGFR Sca-1 cells were defined as 1 for each experiment. Mean ± SEM; n = 6 
per group. (D) Triple IHC of Sca-1 (red), DAPI (blue), and Ang-1 (green, top left) or CXCL12 (green, bottom left). Data are representative of three independent 
recipients. (E) Representative results of flow cytometric analysis for cell-surface markers by using freshly isolated BMMNCs from wild-type C57BL/6 animals 
of three independent experiments. Blue line, isotype control; red line, specific antibodies. Bars: (A, B, and D) 50 µm.JEM VOL. 206, October 26, 2009 
ARTICLE
2489
heterogeneous expression of the endothelial cell marker CD34, 
cultured MSC marker CD90, and endothelial cell/HSC 
marker Tie-2.
PS cells repopulate hematopoietic niche components  
and adipose tissue in vivo
Although the transplantation of mesenchymal stem cells has 
not been believed to be feasible (Wang et al., 2005; Sackstein 
et al., 2008), we and several other groups have reported that 
freshly isolated BM cells can replace a part of mesenchymal or 
stromal cells (Hou et al., 1999; Pereira et al., 1998; Rombouts 
and Ploemacher, 2003; Koide et al., 2007). To examine whether 
naive MSCs can reconstitute the BM in vivo, freshly isolated 
104 PS cells from CAG-EGFP transgenic mice (EGFP+ 
CD45.1) were intravenously injected into lethally irradiated 
recipient mice (EGFP CD45.1) along with 100 CD34KSL 
cells (HSCs sorted from EGFP CD45.1+ mice; Fig. 4). The 
cells derived from PS or HSCs were traceable by their ex-
pression of EGFP or CD45.1, respectively.
At 16 wk, the peripheral blood of 10 out of 10 recipients 
had  been  reconstituted  by  HSC-derived  CD45.1-positive 
cells averaging 81.1 ± 4.9% of the total cells counted (unpub-
lished data). The recipient animals were subsequently sacri-
ficed and BM sections were subjected to whole-mount IHC. 
We found a significant number of PS-derived GFP+ cells in 
the BM and surrounding bone tissue in all recipients. The 
majority of the cells were located in the perivascular region 
or apposing the inner-surface of cortical bone (Fig. 4 A). 
Double IHC for GFP and marker molecules revealed that the 
transplanted PS cells differentiated into reticular cells in as-
sociation with vSMCs (Fig. 4 B, a–c), consistent with the 
normal physiological localization of PS cells (Fig. 3, A and B). 
The CXCL12 (Fig. 4 B, d–f) and Ang-1 (Fig. 4 B, g–i) 
expression in these cells suggested they could reconstitute the 
vascular niche for hematopoiesis. GFP-positive PS cells had 
also differentiated into osteocalcin-expressing osteoblasts 
lining the inner surface of the cortical bone (Fig. 4 B, j–l). 
In addition, in the adipose tissue of recipient mice we found 
some GFP-positive cells that were also positive for perilipin 
(Fig. 4 B, m–o), an adipocyte marker that is specifically ex-
pressed at the periphery of lipid droplets (Cho et al., 2007). 
Combined with the localization of naive PS cells in BM 
shown in Fig. 3 (A–D), these data suggested that within 
16 wk of systemic transplantation, primary PS cells (MSCs), 
which are normally located in the arterial perivascular space 
in association with vSMCs, can give rise to osteoblasts and 
perivascular cells that function as hematopoietic niche cells 
(Fig. S3) or produce adipocytes when the cells migrate to 
adipose tissue.
However, systemically transplanted GFP+ MSCs derived 
from single PS cells in culture were not detectable 8 wk later. 
To investigate this further, 105 1-mo-culture–expanded PS 
cells that had been engineered to express firefly luciferase fused 
to Venus (see Materials and methods) were transplanted into 
lethally irradiated recipient mice. The animals were subjected 
to bioluminescence imaging (BLI) analysis (Okada et al., 2005) 
Figure 4.  Multilineage capacity of transplanted PS cells in vivo. 
Representative pictures of bone specimens from lethally irradiated wild-
type C57BL/6 mice (EGFP CD45.1; n = 5 mice in three independent 
experiments), 16 wk after the intravenous transplantation of 104 PS cells 
from CAG-EGFP transgenic mice BMMNCs (EGFP+ CD45.1) and of 100 
CD34KSL cells from B6-Ly5.1 (EGFP CD45.1+) mice. (A) The boxed areas 
in the top panels are shown enlarged in the bottom panels. Bars: (top) 
100 µm; (bottom) 50 µm. (B) Double IHC of GFP (green; a, d, g, j, and m) 
and either SMA (red; b and c), CXCL12 (red; e and f), Ang-1 (red; h and i), 
osteocalcin (red; k and l), or perilipin (red; n, o). Nuclei were stained with 
DAPI (blue; c, f, i, l, o). Note the GFP+ cells (arrows) differentiated into 
perivascular cells expressing CXCL12, osteoblasts, or adipocytes, but not 
vSMCs (arrowheads). Bars: (c and i) 20 µm; (f, l, o) 50 µm.2490 DIRECT ISOLATION METHOD FOR PDGFR+ SCA-1+ mMSCS | Morikawa et al.
secondary CFU-Fs could be clonally expanded, which would 
indicate their competence for self-renewal. At 16 wk after 
transplantation, the bone and BM of five recipient mice were 
individually collagenase digested into single-cell suspensions. 
Flow cytometric analysis showed that donor-derived GFP+ 
nonhematopoietic (CD45TER119) cells (Fig. 5 A, left) 
were <10% (mean percentage 7.35%), although the percent-
age varied in all cases. Notably, GFP+ cells belonging to pop-
ulations other than PS were found (Fig. 5 A, right). To test 
on days 0, 1, 3, 7, and 14 after transplantation. Strong biolu-
minescent signals in the bilateral lung and neck were observed 
on days 0, 1, and 3, but the signals attenuated below the level 
of detectability by day 7 (Fig. S4). The data strongly support a 
previous observation that MSCs rapidly lose their ability to 
home to an appropriate site when cultured (Rombouts and 
Ploemacher, 2003; Wang et al., 2005).
We further investigated whether transplanted PS cells 
maintained their stem cell properties by observing whether 
Figure 5.  Self-renewal and differentiation capacity of transplanted PS cells. Wild-type B6 animals were intravenously transplanted with freshly 
isolated 104 PS cells. (A) Representative result from flow cytometric analysis of EGFP expression of BMMNCs in recipient mice (n = 5 mice in three inde-
pendent experiments) at 16 wk after transplantation. (B) PS cells from five recipients were then single sorted by flow cytometry and cultured individu-
ally in 96-well tissue culture plates. Bar, 50 µm. Colonies were formed by the sorted single PS, which were able to sustain proliferation in vitro. Bar, 100 
µm. (C) GFP+ PS clones derived from transplanted PS were multipotent and could give rise to adipocytes (left; oil red O staining, day 14), chondrocytes 
(middle; toluidine blue staining, day 21), and osteocytes (right; alkaline phosphatase staining, day 14). Bar, 100 µm.JEM VOL. 206, October 26, 2009 
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The identification of a marker combination that permits 
the isolation of primary MSCs enabled us to examine their 
physiological localization and role in the BM. We found that 
primary MSCs, with abundant Ang-1 expression, were pre-
dominantly in the arterial perivascular space near the inner 
surface of the bone, adjacent to vSMCs. Our data also demon-
strated the in vivo fate of primary MSCs in a systemic trans-
plantation assay. The transplanted primary MSCs (PS cells) 
mainly  differentiated  into  osteoblasts  and  Ang-1–  and/or 
CXCL12-expressing perivascular cells, consistent with a re-
cent study (Sacchetti et al., 2007). Collectively, our data con-
clusively demonstrate that primary MSCs and their descendants 
mainly function in the adult BM as a hematopoietic niche in 
the arterial perivascular area in BM (Doherty et al., 1998; Shi 
and Gronthos, 2003).
One of the most important observations of this study is 
that intravenously transplanted PS cells were integrated not 
only into the BM but also into adipose tissue. Previous studies 
have largely indicated that MSCs are not transplantable. The 
systemic delivery of in vitro–isolated MSCs to recipient ani-
mals, although feasible, has been limited by the entrapment of 
donor cells in tissues, primarily the lungs, and the few success-
ful transplantations were mostly performed by direct local or 
intralesional implantation (Miyahara et al., 2006; Muguruma 
et al., 2006).
As has been reported (Rombouts and Ploemacher, 2003), 
we found that cultured MSCs lost their homing ability. In ad-
dition, after ex vivo expansion, even the PS cells were largely 
trapped in the lung (Fig. S4) and did not contribute to any 
BM compartment. Cell migration and tissue integration in-
volve a cascade of events initiated by shear-resistant adhesive 
interactions between flowing cells and the vascular endothe-
lium at the target tissue. This process is mediated by “homing 
receptors” expressed on circulating cells that engage relevant 
endothelial coreceptors, resulting in cell-tethering and rolling 
contacts on the endothelial surface; this is typically followed 
by chemokine-triggered activation of integrin adhesiveness, 
firm adhesion, and extravasation (Sackstein, 2005). The key 
molecule that mediates the homing capacity of primary MSCs 
is unknown, and its identification should be addressed in a fu-
ture study. In addition, it is also possible that BM engrafted 
cells and CFU-Fs were derived from a distinct cell population 
because PS cells still contain a heterogeneous population of 
cells.  Thus,  further  purification  and  clonal  transplantation 
studies would be necessary to prove our hypothesis.
Although cultured MSCs are multipotent in vitro, the 
cells often commit to the osteocyte lineage after local implan-
tation (Sacchetti et al., 2007). We found that transplanted 
PS cells that migrated to the BM mainly produced niche 
cells, as described above, but the cells that localized to adipose 
tissue  differentiated  into  mature  adipocytes.  These  results 
strongly suggested that primary MSCs can home to their ap-
propriate niche and differentiate in response to cues from the 
local microenvironment. However, the discrepancy in dif-
ferentiation potential between the in vitro and in vivo data 
remains to be addressed. In the in vitro differentiation assay, 
if the recovered PS cells retained their stem cell properties,   
we sorted single PS cells into individual wells of 96-well 
plates, and analyzed the resulting colonies. GFP+ fibroblastic 
colonies generated from 2 of 96 cells (Fig. 5 B), and the 2 
clones retained the ability to undergo sustained growth, as well 
as the multilineage differentiation potential in vitro (Fig. 5 C).
PS cells are resistant to whole-body irradiation
Although  our  data  showed  that  the  prospectively  isolated 
PS cells (primary MSCs) migrated to appropriate sites and 
differentiated into the expected cell types after systemic infu-
sion, the mean chimerism resulting from the transplantation 
of 104 PS-derived cells was 7%. In contrast, 100 purified 
HSCs were sufficient to reconstitute >80% of the hemato-
poietic cells (Fig. 6 A). Given that 104 PS cells contained 
500 CFU-Fs, based on our 1/20 frequency of CFU-Fs in 
PS cells (Fig. 1 H), the PS engraftment was lower than 
expected. The observed difference might have been caused 
by the irradiation protocol. That is, if the recipient’s MSCs 
had not been eliminated in sufficient numbers to leave their 
niche available to the donor MSCs, competition for the niche 
might  have  reduced  the  number  of  successfully  engrafted 
cells (Rombouts and Ploemacher, 2003; Koide et al., 2007). 
To evaluate this hypothesis, we compared the susceptibility 
of HSCs (KSL) and MSCs (PS) to irradiation.
Three mice in each group were subjected to whole-body 
irradiation at a dose of 10.5 Gy, a significant number of PS 
cells remained among the BMNNCs after 6 d, but the HSCs 
(KSL cells) were almost undetectable by flow cytometry (Fig. 6, 
B and D). Interestingly, the sorted PS cells from the irradi-
ated animals mostly failed to form colonies, and the CFU-F 
frequency was reduced to 1.66 ± 0.57% (33 ± 5.0% in unir-
radiated; Fig. 6 C). Because irradiation normally induces cell 
death in actively cycling cells, we reasoned that the MSC/
PS cells were quiescent. Flow cytometric analysis for cell-
cycle markers showed that 71% of freshly isolated PS cells 
were in the G0 phase (Fig. 6 E), which could have protected 
them from lethal irradiation. These findings suggest that a 
significant proportion of the PS cells are physiologically qui-
escent and therefore resistant to radiation damage and myelo-
toxicity in vivo.
DISCUSSION
Using cell-surface markers and flow cytometry, we succeeded 
in prospectively isolating MSCs as PDGFR+Sca-1+CD45 
TER119 (PS) cells from adult murine BM. We showed 
that PS cells have primitive characteristics consistent with 
conventional MSC populations isolated by adhesion culture. 
Because PS cells were detected in various mouse strains 
(Fig. S1) with equal CFU-F frequency and differentiation 
potency, our protocol has immense potential for isolating en-
riched, primary MSCs for detailed analyses especially in vari-
ous genetically modified animals. Unlike with conventional 
protocols, our protocol permits such studies to be done with 
minimal contamination by unnecessary cells or the potential 
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Figure 6.  In vivo effects of lethal irradiation on the quiescence of PS cells. HSCs (CD34KSL) from B6-Ly5.1 (CD45.1) mice and PS cells (MSCs) 
from CAG-EGFP transgenic mice were transplanted together into lethally irradiated B6-Ly5.2 mice to examine the competitive repopulation of the appro-
priate niches. The graph shows the percentage of CD45.1 and GFP donor-derived cells detected in the BM of recipient mice 16 wk after transplantation 
(CD45.1, 81.1 ± 4.95%; GFP+, 7.4 ± 0.40%.; n = 3 per group in three independent experiments). (B) The numbers of HSCs (KSL, c-Kit+Sca-1+Lin) and MSCs 
(PS, PDGFR+Sca-1+) in the BM were calculated by ([Total number of BMMNCs] × [% of the cells] /100). Black bar, untreated control mice; gray bar,  
irradiated mice, 10 d after lethal irradiation. Results are means ± SEM (n = 3 per group). (C) The number of CFU-Fs formed from PS cells isolated from 
either of unirradiated control (black) or lethally irradiated (Gray) wild-type C57BL/6. Means ± SEM (n = 3 per group). (D) Representative flow cytometric 
analysis of HSCs (KSL, top) or MSCs (PS, bottom) in BMMNCs of lethally irradiated or unirradiated control mice. (E) Flow cytometry analysis of  
PY/Hoechst-stained PS cells of unirradiated (left) and lethally irradiated (right) mice. Data are representative of three independent experiments.JEM VOL. 206, October 26, 2009 
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our animal facility at Keio University School of Medicine. All experimental 
procedures and protocols were approved by the ethics committee of Keio 
University and were in accordance with the Guide for the Care and Use of 
Laboratory Animals.
Preparation of BM cell suspension
Femurs and tibias were dissected and crushed with a pestle. The crushed 
bones were gently washed once in HBSS+ (Hanks-balanced salt solution 
supplemented with 2% FBS, 10 mM Hepes, and 1% penicillin/streptomycin), 
and the cell suspension filtered through a cell strainer (Falcon 2350) was 
discarded. The bone fragments were collected and incubated for 1 h at 37°C 
in 20 ml of DMEM (Invitrogen) containing 0.2% collagenase (Wako Chem-
icals USA, Inc.), 10 mM Hepes and 1% P/S. The suspension was filtered 
with a cell strainer (Falcon 2350) to remove debris and bone fragments, and 
collected by centrifugation at 280 g for 7 min at 4°C. The pellet was im-
mersed in 1 ml water (Sigma-Aldrich) for 5–10 s to burst the red blood cells, 
after which 1 ml of 2× PBS (dilution from Sigma-Aldrich) containing 4% 
FBS was added, and the suspension was filtered through a cell strainer.
Antibody staining
The cells were suspended in ice-cold HBSS+ at 1–5 × 107 cells/ml, and then 
stained for 30 min on ice with the following mAbs: biotinylated or APC-
conjugated PDGFR (APA5), FITC-conjugated Sca-1 (Ly6A/E), PE-con-
jugated CD45 (30-F11), and TER119 (TER-119). Biotinylated antibodies 
were visualized with APC-conjugated streptavidin (Invitrogen). All mAbs 
were purchased from eBioscience. Flow cytometry analysis and sorting 
were performed on a triple-laser MoFlo (Dako) or FACSCalibur (BD) flow 
cytometer. PI fluorescence was measured, and a live cell gate was defined 
that excluded the cells positive for PI. Additional gates were defined as posi-
tive for PDGFR and Sca-1 and negative for CD45 and TER119, accord-
ing to the isotype control fluorescence intensity.
Cell culture
A variety of culture methods were required for this study, including adherent 
culture, CFU-F assay, cultures for MSC differentiation into mature cells, and 
CFU-C assay.
Adherent culture. Traditional MSC adherent culture was performed as 
described previously (Pittenger et al., 1999). Sorted cells were cultured in 
maintenance medium (i.e., MEM + GlutaMAX-I [Invitrogen] supple-
mented with 10% FBS and antibiotics), incubated at 37°C with 5% CO2, 
and maintained with exchanges into fresh medium every 3–4 d for 2–3 wk.
CFU-F assay. Approximately 1 × 103 or 2 × 103 sorted cells were seeded 
on a 100-mm dish in maintenance medium. Adherent cell clusters contain-
ing >50 cells were counted as a colony.
Differentiation cultures. To induce adipocyte differentiation, subconflu-
ent cells were cultured with three cycles of Adipogenic Induction Medium/
Adipogenic Maintenance Medium, with supplements from the Adipogenic 
Induction/Adipogenic  Maintenance  SingleQuot  kit  (Lonza).  Each  cycle 
consisted of feeding the subconfluent cells with the induction medium for 3 
d, followed by 3 d of culture in the maintenance medium. After 14 d, the 
cells were fixed with 4% paraformaldehyde for 15 min, and stained with oil 
red O (MutoPure Chemicals).
For chondrogenic differentiation, cultured cells were harvested by tryp-
sinization. The 2 × 104–2.5 × 105 cells were transferred into a 15-ml conical 
tube and washed with MEM + GlutaMAX (Invitrogen). The tube was 
spun at 150 g for 5 min at room temperature, and the supernatant was aspi-
rated. The cells were resuspended in 1 ml Differentiation Basal Medium 
Chondrogenic, with supplements from the Chondrogenic SingleQuot kit 
(Lonza), spun at 150×g for 5 min, and the medium was aspirated. The cells 
were resuspended in 1 ml of Differentiation Basal Medium Chondrogenic, 
supplemented  with  Chondrogenic  SingleQuots  kit,  TGF-b3  (10  ng/ml; 
Lonza) and BMP-6 (500 ng/ml; R&D Systems), and spun at 150 g for 5 min 
at room temperature. The pellet was maintained with Differentiation Basal 
single PS-derived MSCs differentiated not only into chon-
drocytes and osteocytes, but also into endothelial cells and 
adipocytes. However, the primary PS cells did not integrate 
into vSMCs in vivo. In addition, at least within 3 mo after 
transplantation, there were no detectable PS-derived adipo-
cytes in the BM. One explanation may be that naive MSCs 
are extremely sensitive to tissue level elasticity in the micro-
environment  and  commit  to  specific  lineages  accordingly 
(Engler et al., 2006).
These findings have important clinical implications. Pri-
mary MSCs transplanted by systemic infusion may be useful 
for cell therapy of various systemic skeletal diseases, such 
as dyschondroplasia, osteochondrodysplasia, osteoporosis, and 
osteogenesis imperfecta. In contrast, local implantation is in-
vasive and can result in significant morbidity, potentially dis-
rupt the highly complex and delicate structure of the local 
regulatory microenvironment, and cause additional injury. 
Thus, stem cell–based therapy for systemic disorders man-
dates vascular delivery. However, this approach is limited by 
the difficulty of ensuring that sufficient numbers of reconsti-
tuting cells reach the damaged areas in cases of ineffective 
stem cell engraftment (Laver et al., 1987; Simmons et al., 
1987; Agematsu and Nakahori, 1991; Awaya et al., 2002; 
Stute et al., 2002; Barbash et al., 2003; Meyerrose et al., 
2007). Here, we demonstrated the detection of significant 
number of primary PS-derived cells in the BM of trans-
plant-recipient animals; however, the low engraftment activ-
ity of MSCs remains an unsolved problem. A key feature of 
stem cells is that they are in a quiescent state in vivo. Our re-
sults clearly revealed that >70% of PS were in the G0 phase, 
and the frequency of quiescent PS in the BM did not change 
after lethal irradiation. These data demonstrate that although 
the radiation reduced the host CFU-F colony-forming ability 
in vitro, it did not physically kill the cells; instead, they re-
mained alive, but mostly nonfunctional, in their niche. Find-
ing nondeleterious ways to remove host MSCs, assuming that 
the cell cycle progression of transplanted MSCs can be in-
duced, to expand the progenitor population and compensate 
for cell loss, will be our next challenge. If we succeed, freshly 
isolated MSCs could have great potential for correcting bone 
and BM-related systemic disorders.
Overall, the approach detailed here provides a means for 
researchers to study the therapeutic potential of cells from BM 
as a cell source for bone components and to elucidate how in-
dividual factors function in the control and maintenance of 
bone and BM formation in vivo and in a variety of health and 
disease states. Advances in this field hold promise for the devel-
opment of rationale-based stem cell therapies for tissue regen-
eration and of gene therapy for inherited disorders.
MATERIALS AND METHODS
Mice
Adult wild-type C57BL/6 mice and B6.SJL-Ptprca Pep3b/BoyJ (C57BL/6-
Ly5.1;Ly5.1) mice 8–12 wk of age were purchased from CLEA Japan, Inc. 
(Tokyo, Japan). Transgenic mice that ubiquitously express EGFP under the 
control of the CAG promoter (Kawamoto et al., 2000) were bred in our ani-
mal facility. The mice were kept under specific pathogen–free conditions in 2494 DIRECT ISOLATION METHOD FOR PDGFR+ SCA-1+ mMSCS | Morikawa et al.
bioluminescent protein which emitted bigger bioluminescent signals than 
general one, only 105 cells could be detected easily. Sorted single PS cell 
was cultured and proliferated, infected with lentivirus, continuously propa-
gated, harvested, and then dissociated into single cells. The PI-negative/Ve-
nus-positive PS cells were sorted by a flow cytometry and transplanted 
with HSCs (34-KSL).
BLI
We used a Xenogen-IVIS 100–cooled CCD optical macroscopic imaging 
system (SC BioScience Corporation) for BLI. For in vivo imaging, recipient 
mice transplanted with lentivirally engineered PS cells were anesthetized 
and given D-luciferin (150 mg/kg body weight) i.p. We found this time 
window to be optimal because the signal intensity peaked at 15 min after ad-
ministration followed by a plateau of 20 min (unpublished data). All images 
were analyzed as described in Materials and methods. To quantify the mea-
sured light, regions of interest (ROI) were defined as lungs and all values 
were examined from an equal ROI.
Statistical analysis.
The Tukey-Kramer test was used to compare the frequencies of CFU-Fs 
among different groups. All reported p-values were obtained using the SPSS 
software package (SPSS 15.0J for Windows).
Online supplemental material
Fig. S1 shows the quantification and differentiation of PS cells isolated from 
different inbred mouse strains. Fig. S2 shows cell surface marker antigens of 
clonally cultured PS cells. Fig. S3 is a schematic model of the physiological 
localization and behavior of MSCs in BM. Fig. S4 shows imaging of trans-
planted cultured MSCs in vivo. Table S1 lists primers used in this study. Table 
S2 lists monoclonal antibodies used in this study.Online supplemental ma-
terial is available at http://www.jem.org/content/full/jem.20091046/DC1.
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